Skip to main content
. 2020 Jun 26;26:472–482.

Table 4. Paired comparison of vitreous and serum samples from patients with PDR – median (minimum-maximum); Wilcoxon signed rank test.

Cytokine patients with PDR (n=33)
  vitreous serum P value
MCP-1 (pg/ml)
1614.98 (403.05–3990.74)
72.6 (25.06–169.65)
0.0001
IL-8 (pg/ml)
93.29 (20.04–295.71)
11.99 (10.12–31.69)
0.0001
IL-6 (pg/ml)
60.82 (13.64–798.23)
5.46 (2.41–24.76)
0.0001
VEGF (pg/ml)
304.64 (26.41–1439.3)
38.66 (6.17–105.56)
0.0001
IL-1β (pg/ml)
9.15 (7.51–67.36)
7.6 (6.91–15.16)
0.002
TNF-α (pg/ml)
13.41 (3.26–69.09)
5.7 (2.9–23.35)
0.005
MIP-1α (pg/ml)
9.55 (6.9–68.26)
15.07 (7.78–91.74)
0.002
MIP-1β (pg/ml)
12.09 (2.9–38.02)
18.76 (6.89–48.83)
0.009
IL-10 (pg/ml)
5.67 (4.9–8.12)
7.4 (5.3–15.28)
0.001
IL-12 (pg/ml) 3.17 (0.68–22.26) 17.7 (2.49–42.91) 0.0001

Legend: PDR – proliferative diabetic retinopathy; IL-1β - interleukin-1β; TNF-α - tumor necrosis factor-α; MIP-1α - macrophage inflammatory protein-1α; MIP-1β - macrophage inflammatory protein-1β; MCP-1 - monocyte chemoattractant protein-1; IL-6 - interleukin-6; IL-8 - interleukin-8; IL-10 - interleukin-10; IL-12 - interleukin-12; VEGF - vascular endothelial growth factor